首页> 美国卫生研究院文献>Current Medical Mycology >In vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infections

【2h】

In vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infections

机译：与三种常见抗真菌药相比益康唑对从浅表感染中分离的临床念珠菌菌株的体外活性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and Purpose: Candida species are the most common organisms involved in superficial fungal infections, worldwide. Although econazole is among the most frequently used topical formulations for the treatment of candidiasis, no information is available regarding the susceptibility profiles of Candida species in Iran.

机译：背景与目的：念珠菌是全世界浅表真菌感染中最常见的生物。尽管益康唑是治疗念珠菌病最常用的局部制剂之一，但尚无关于伊朗念珠菌物种敏感性的信息。

著录项

期刊名称 Current Medical Mycology
作者
M Abastabar; T Shokohi; R Rouhi Kord; H Badali; SJ Hashemi; Z Ghasemi; A Ghojoghi; N Baghi; M Abdollahi; S Hosseinpoor; N Rahimi; Z Seifi; S Gholami; I Haghani; MR Jabari; A Pagheh;
展开▼
作者单位

展开▼
年(卷),期 2015(1),4
年度 2015
页码 7–12
总页数 6
原文格式 PDF
正文语种
中图分类微生物学;
关键词
入库时间 2022-08-17 12:57:22

相似文献

外文文献
中文文献
专利

1. In Vitro Activities of Voriconazole as a Triazole Derivative and Caspofungin as an Echinocandin Were Compared with Those of Some Antifungal Agents against Candida Species Isolated from Clinical Specimens. [J] . Ozcelik B, Kaynak F, Cesur S, Japanese journal of infectious diseases . 2007,第5期

机译：比较了Voriconazole作为三唑衍生物和Caspofungin作为Echinocandin的体外活性与一些针对从临床标本中分离出的念珠菌的抗真菌剂的活性。
2. Impact of the New Clinical Breaking Points Proposed by the Clinical and Laboratory Standards Institute (CLSI) in the Antifungal Susceptibility Profile of Clinical Strains Isolated from Invasive Bloodstream Candida Spp. Infections in Spain [J] . R. Cisterna, O. Teller?a, S. Hernaez, Clinical Medicine Insights: Therapeutics . 2012,第4期

机译：临床和实验室标准协会（CLSI）提出的新临床突破点对从侵袭性血液念珠菌属分离的临床菌株的抗真菌药敏性方面的影响。西班牙的感染
3. In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp. [J] . Tetz G., Collins M., Vikina D., Antimicrobial agents and chemotherapy. . 2019,第4期

机译：新型抗真菌化合物MyC-053的体外活性，对抗临床显着的抗阴性抗阴性抗念珠菌，Candida Auris，Cryptococcus Neoformans和Pneumocystis SPP。
4. Effect of antifungal agents on non-Candida albicans Candida species enzymatic activity [C] . M. Negri, T. Loren?o, S. Silva, International Conference on Antimicrobial Research . 2011

机译：抗真菌剂对非念珠菌白醛念珠菌物种酶活性的影响
5. Enhancement of Drug Release and Antifungal Activity of Econazole from Dermatological Formulations Using Reduced Level of Drug. [D] . Aguirre, Elizabeth T. 2017

机译：使用降低的药物水平增强皮肤科制剂中益康唑的药物释放和抗真菌活性。
6. In Vitro Activity of a Novel Antifungal Compound MYC-053 against Clinically Significant Antifungal-Resistant Strains of Candida glabrata Candida auris Cryptococcus neoformans and Pneumocystis spp. [O] . G. Tetz, M. Collins, D. Vikina, 2019

机译：新型抗真菌化合物MYC-053的体外活性对光滑念珠菌金黄色念珠菌新隐球菌和肺孢菌的临床上重要的抗真菌菌株具有抗性。
7. In vitro activity of a novel antifungal compound, MYC-053, against clinically significant antifungal-resistant strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp [O] . G Tetz, M Collins, D Vikina, 2018

机译：新型抗真菌化合物，MyC-053的体外活性，对抗临床显着的抗阴性抗阴性抗阴性抗阴性抗性抗性抗阴性抗性，念珠菌，念珠菌，碱性抗球菌和肺炎

In vitro activity of econazole in comparison with three common antifungal agents against clinical Candida strains isolated from superficial infections

摘要

著录项

相似文献

相关主题

期刊订阅